Bioavailable Vitamin D Redefines Vitamin D Deficiency
Bioavailable Vitamin D Redefines Vitamin D Deficiency
批准号:
8331000
负责人:
RAVI THADHANI
金额:
$39.4万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-17 至 2015-05-31
关键词:
AdultAffectAfrican AmericanBioavailableBiologicalBiological AssayBiologyBlood specimenBone DensityBone DiseasesCaucasiansCaucasoid RaceClinicalClinical Trials DesignComplexConsensusDataDiabetes MellitusDiagnosisDiseaseDisease OutcomeEnd stage renal failureEnrollmentExhibitsFractureFutureGeneral PopulationGenesGenetic PolymorphismHealthcareHormonesHumanIndividualInterdisciplinary StudyLinkLongevityMalignant NeoplasmsMeasuresMinorityNeighborhoodsOsteoporosisOutcomePatientsPhysiologicalPopulationPopulation HeterogeneityPregnant WomenPrevalenceProphylactic treatmentProtein BindingPublic HealthRaceReportingResearchResourcesRiskSupplementationTestingTherapeuticVariantVitamin DVitamin D DeficiencyVitamin D-Binding ProteinWorkbasecardiovascular disorder riskcardiovascular infectionclinical decision-makingclinically relevantcohortcosthealthy aginghealthy volunteerhigh riskimprovedinnovationnovelpreventpublic health prioritiesracial differenceyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Vitamin D deficiency has been associated with bone disease and a host of other major non-skeletal diseases including cardiovascular, infection, cancer and diabetes. Although supplementation may reduce risks, the definitions and cutoffs that establish clinically relevant vitamin D deficiency across racially diverse populations lack consensus. As a public health priority, it is critical to determine who needs to be treated to optimally affect disease outcomes. Blacks consistently have low 25-hydroxy vitamin D (25[OH] D) levels but paradoxically have higher bone mineral density (BMD) and lower osteoporosis risk than whites. Should blacks be treated with vitamin D to prevent osteoporosis? We propose to investigate a novel concept that vitamin D binding protein (VDBP), in the context of the "free hormone hypothesis," underlies the physiological mechanisms of this paradox. We recently reported in healthy young adults that VDBP levels: (1) directly correlate with total 25(OH)D levels; (2) inversely correlate with free- and bioavailable-25(OH)D; and, importantly, (3) vary with race. Preliminary data collected by our research team in patients with ESRD and in pregnant women are consistent with these observations. Others have shown that polymorphisms of the VDBP gene exhibit marked racial differences, suggesting that VDBP modulates vitamin D activity. It is therefore likely that all blacks do not have profound free and bioavailable vitamin D deficiency. We plan to determine the influence of circulating VDBP on bioavailable 25(OH) D by comparing stored blood samples from a large (n~2,200) population of black and white subjects enrolled in HANDLS (Healthy Aging in Neighborhoods of Diversity across the Life Span (available at http://handls.nih.gov) to test the following hypotheses: 1. Blacks have lower levels of VDBP and total 25(OH) D, but similar levels of free and bioavailable 25(OH) D as whites. 2. Free and bioavailable 25(OH)D levels are independently associated with BMD in blacks and whites, inversely and linearly associated with PTH levels, and these associations are stronger than those between total 25(OH)D and BMD. Our specific aims are to: (1) determine VDBP, total and bioavailable 25(OH)D, and PTH levels; and (2) test for associations between BMD, bioavailable 25(OH)D, and PTH compared to total 25(OH)D.
PUBLIC HEALTH RELEVANCE: According to the standard definition, vitamin D deficiency is extremely common in the general population and has been linked with bone disease. Vitamin D, however, circulates in different forms, and this application will determine which specific forms of
vitamin D are most strongly linked with bone mineral density in a large population of Blacks and Caucasians in the U.S., and therefore who would be most appropriate to treat for vitamin D deficiency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Support of the Emory National Primate Research Center
-
批准号:10844283
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2023
-
负责人:RAVI THADHANI
-
依托单位:
PDE5i with Tadalafil Changes the Extent of Renal Damage (PITCH_ER)
-
批准号:8606587
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2013
-
负责人:RAVI THADHANI
-
依托单位:
Impact of vitamin D supplementation on cardiac structure and function
-
批准号:8268146
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Impact of vitamin D supplementation on cardiac structure and function
-
批准号:8626441
-
项目类别:
-
资助金额:$29.48万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Impact of vitamin D supplementation on cardiac structure and function
-
批准号:8431335
-
项目类别:
-
资助金额:$28.63万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Impact of vitamin D supplementation on cardiac structure and function
-
批准号:9292464
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease
-
批准号:8279507
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Bioavailable Vitamin D Redefines Vitamin D Deficiency
-
批准号:8511620
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease
-
批准号:9026599
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease
-
批准号:8638000
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Impact of vitamin D supplementation on cardiac structure and function
-
批准号:8826165
-
项目类别:
-
资助金额:$26.45万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease
-
批准号:8459458
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2012
-
负责人:RAVI THADHANI
-
依托单位:
Dialysis Infection and Vitamin D in New England: The DIVINE Study
-
批准号:8143959
-
项目类别:
-
资助金额:$45.64万
-
财政年份:2011
-
负责人:RAVI THADHANI
-
依托单位:
Dialysis Infection and Vitamin D in New England: The DIVINE Study
-
批准号:8332113
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2011
-
负责人:RAVI THADHANI
-
依托单位:
Translational Studies Examining Soluble EPO Receptor and EPO Resistance in Dialys
-
批准号:8049954
-
项目类别:
-
资助金额:$32.6万
-
财政年份:2010
-
负责人:RAVI THADHANI
-
依托单位:
Soluble EPO Receptor and EPO Resistance in Dialysis
-
批准号:8204522
-
项目类别:
-
资助金额:$17.55万
-
财政年份:2010
-
负责人:RAVI THADHANI
-
依托单位:
Ergocalciferol in ESRD Efficacy Safety and Biology
-
批准号:7760446
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2009
-
负责人:RAVI THADHANI
-
依托单位:
Ergocalciferol in ESRD Efficacy Safety and Biology
-
批准号:7942951
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2009
-
负责人:RAVI THADHANI
-
依托单位:
METABOLIC ALTERATIONS IN WOMEN WITH A HISTORY OF HYPERTENSIVE DISORDERS OF PREG
-
批准号:7731310
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2008
-
负责人:RAVI THADHANI
-
依托单位:
Vitamin D and Cardiovascular Disease
-
批准号:7614118
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2008
-
负责人:RAVI THADHANI
-
依托单位:
海外基金